702 related articles for article (PubMed ID: 25598171)
1. Prolonged hypogonadism in males following withdrawal from anabolic-androgenic steroids: an under-recognized problem.
Kanayama G; Hudson JI; DeLuca J; Isaacs S; Baggish A; Weiner R; Bhasin S; Pope HG
Addiction; 2015 May; 110(5):823-31. PubMed ID: 25598171
[TBL] [Abstract][Full Text] [Related]
2. Effects of Anabolic Androgenic Steroids on the Reproductive System of Athletes and Recreational Users: A Systematic Review and Meta-Analysis.
Christou MA; Christou PA; Markozannes G; Tsatsoulis A; Mastorakos G; Tigas S
Sports Med; 2017 Sep; 47(9):1869-1883. PubMed ID: 28258581
[TBL] [Abstract][Full Text] [Related]
3. Former Abusers of Anabolic Androgenic Steroids Exhibit Decreased Testosterone Levels and Hypogonadal Symptoms Years after Cessation: A Case-Control Study.
Rasmussen JJ; Selmer C; Østergren PB; Pedersen KB; Schou M; Gustafsson F; Faber J; Juul A; Kistorp C
PLoS One; 2016; 11(8):e0161208. PubMed ID: 27532478
[TBL] [Abstract][Full Text] [Related]
4. The use of post-cycle therapy is associated with reduced withdrawal symptoms from anabolic-androgenic steroid use: a survey of 470 men.
Grant B; Kean J; Vali N; Campbell J; Maden L; Bijral P; Dhillo WS; McVeigh J; Quinton R; Jayasena CN
Subst Abuse Treat Prev Policy; 2023 Nov; 18(1):66. PubMed ID: 37951896
[TBL] [Abstract][Full Text] [Related]
5. [The frequency of formation of a motivated refusal to take androgenic anabolic steroids by men with recreational activity].
Lykhonosov MP; Babenko AY; Makarin VA; Fedotov YN
Probl Endokrinol (Mosk); 2019 Nov; 65(5):341-350. PubMed ID: 32202738
[TBL] [Abstract][Full Text] [Related]
6. Factors predicting normalization of reproductive hormones after cessation of anabolic-androgenic steroids in men: a single center retrospective study.
Grant B; Campbell J; Pradeep A; Burns AD; Bassett P; Abbara A; Saket P; Minhas S; Dhillo WS; McVeigh J; Bhasin S; Jayasena CN
Eur J Endocrinol; 2023 Dec; 189(6):601-610. PubMed ID: 38102386
[TBL] [Abstract][Full Text] [Related]
7. Serum Insulin-like Factor 3 Levels Are Reduced in Former Androgen Users, Suggesting Impaired Leydig Cell Capacity.
Rasmussen JJ; Albrethsen J; Frandsen MN; Jørgensen N; Juul A; Kistorp C
J Clin Endocrinol Metab; 2021 Jun; 106(7):e2664-e2672. PubMed ID: 33693710
[TBL] [Abstract][Full Text] [Related]
8. Anabolic steroid induced hypogonadism in young men.
Coward RM; Rajanahally S; Kovac JR; Smith RP; Pastuszak AW; Lipshultz LI
J Urol; 2013 Dec; 190(6):2200-5. PubMed ID: 23764075
[TBL] [Abstract][Full Text] [Related]
9. Clustering psychopathology in male anabolic-androgenic steroid users and nonusing weightlifters.
Jørstad ML; Scarth M; Torgersen S; Pope HG; Bjørnebekk A
Brain Behav; 2023 Jul; 13(7):e3040. PubMed ID: 37150843
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular Toxicity of Illicit Anabolic-Androgenic Steroid Use.
Baggish AL; Weiner RB; Kanayama G; Hudson JI; Lu MT; Hoffmann U; Pope HG
Circulation; 2017 May; 135(21):1991-2002. PubMed ID: 28533317
[TBL] [Abstract][Full Text] [Related]
11. Anabolic steroid-induced hypogonadism: diagnosis and treatment.
Rahnema CD; Lipshultz LI; Crosnoe LE; Kovac JR; Kim ED
Fertil Steril; 2014 May; 101(5):1271-9. PubMed ID: 24636400
[TBL] [Abstract][Full Text] [Related]
12. Severe biventricular cardiomyopathy in both current and former long-term users of anabolic-androgenic steroids.
Abdullah R; Bjørnebekk A; Hauger LE; Hullstein IR; Edvardsen T; Haugaa KH; Almaas VM
Eur J Prev Cardiol; 2024 Mar; 31(5):599-608. PubMed ID: 37992194
[TBL] [Abstract][Full Text] [Related]
13. Body Image Disorders and Anabolic Steroid Withdrawal Hypogonadism in Men.
Pope HG; Kanayama G
Endocrinol Metab Clin North Am; 2022 Mar; 51(1):205-216. PubMed ID: 35216717
[TBL] [Abstract][Full Text] [Related]
14. Use, Misuse and Abuse of Testosterone and Other Androgens.
Linhares BL; Miranda EP; Cintra AR; Reges R; Torres LO
Sex Med Rev; 2022 Oct; 10(4):583-595. PubMed ID: 37051948
[TBL] [Abstract][Full Text] [Related]
15. The Anabolic 500 survey: characteristics of male users versus nonusers of anabolic-androgenic steroids for strength training.
Ip EJ; Barnett MJ; Tenerowicz MJ; Perry PJ
Pharmacotherapy; 2011 Aug; 31(8):757-66. PubMed ID: 21923602
[TBL] [Abstract][Full Text] [Related]
16. Anabolic androgenic steroid-induced hypogonadism, a reversible condition in male individuals? A systematic review.
Vilar Neto JO; da Silva CA; Bruno da Silva CA; Pinto DV; Caminha JSR; de Matos RS; Nunes Filho JCC; Alves FR; Magalhães SC; De Francesco Daher E
Andrologia; 2021 Aug; 53(7):e14062. PubMed ID: 33887077
[TBL] [Abstract][Full Text] [Related]
17. Psychological and physical impact of anabolic-androgenic steroid dependence.
Ip EJ; Lu DH; Barnett MJ; Tenerowicz MJ; Vo JC; Perry PJ
Pharmacotherapy; 2012 Oct; 32(10):910-9. PubMed ID: 23033230
[TBL] [Abstract][Full Text] [Related]
18. The Central Effects of Androgenic-anabolic Steroid Use.
Mędraś M; Brona A; Jóźków P
J Addict Med; 2018; 12(3):184-192. PubMed ID: 29470183
[TBL] [Abstract][Full Text] [Related]
19. Reversible hypogonadism and azoospermia as a result of anabolic-androgenic steroid use in a bodybuilder with personality disorder. A case report.
Boyadjiev NP; Georgieva KN; Massaldjieva RI; Gueorguiev SI
J Sports Med Phys Fitness; 2000 Sep; 40(3):271-4. PubMed ID: 11125771
[TBL] [Abstract][Full Text] [Related]
20. Use, Misuse and Abuse of Testosterone and Other Androgens.
Linhares BL; Miranda EP; Cintra AR; Reges R; Torres LO
Sex Med Rev; 2022 Oct; 10(4):583-595. PubMed ID: 34887237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]